ReviewCancer Lett2023
Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.
- Journal
- Cancer Lett
- Published
- 29 March 2023
- Citations
- 12
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 7
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Pancreatic cancer variant analysis of the All of Us cohort P20GM121316↗
- Targets, Modulators and Delivery Program P30CA036727↗
- MUC16 in Pancreatic Cancer Progression and Metastasis R01CA208108↗
- Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer R01CA256973↗
- Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer R01CA259080↗
- Pancreatic Cancer Detection Consortium U01CA210240↗